Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NRx Pharmaceuticals Announces Advance $5M Milestone Payment From Alvogen And Lotus Pharmaceutical

Author: Benzinga Newsdesk | February 12, 2024 08:35am
  • Companies continue to work collaboratively to advance NRX-101 through registrational trials
  • NRx remains eligible for an additional $324 million in development and sales milestones, as well as tiered double-digit royalties upon approval and commercialization of NRX-101.
    • Payment materially extends the Company's cash runway

Posted In: NRXP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist